Experiment 67615
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | ZHANG,XY: ZHOU,DF: SU,JM: ZHANG,PY:. (2001). THE EFFECT OF EXTRACT OF GINKGO BILOBA ADDED TO HALOPERIDOL ON SUPEROXIDE DISMUTASE IN IN PATIENTS WITH CHRONIC SCHIZOPHRENIA.. 21(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL ASSESSED THE EFFECT OF HALOPERIDOL PLUS GINKGO ON TREATMENT-RESISTANT CHRONIC SCHIZOPHRENIA AND SUPEROXIDE DISMUTASE LEVELS. FORTY-THREE PATIENTS WERE TREATED WITH HALOPERIDOL PLUS EXTRACT OF GINKGO BILOBA (GROUP 1), AND 39 RECEIVED HALOPERIDOL PLUS PLACEBO (GROUP 2). SOD LEVELS OF THESE PATIENTS WERE MEASURED BEFORE AND AFTER TREATMENT. PATIENTS IN GRUOP 1 IMPROVED SIGNIFICANTLY AS DEMONSTRATED FROM TWO ASSESSMENT INSTRUMENTS. AFTER TREATMENT, THE SOD LEVEL DECREASED SIGNIFICANTLY IN GROUP 1 BUT NOT IN GROUP 2. |
| Dose amount | 360.0 MG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ACETONE EXT |
| Gender | GIVEN TO BOTH SEXES |